ScreenerHero

ATORXAlligator Bioscience AB (publ)

STO · SE · Healthcare · Biotechnology · alligatorbioscience.se
0.0311SEK+2.64%Mkt Cap: 1.87M $P/E: —

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Belgium. The company develops Mitazalimab, a stimulatory antibody that targets CD40,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap1.87M $
Enterprise Value1.76M $
Revenue (TTM)49.74K $
Gross Profit-5.75M $
Net Income (TTM)-4.91M $
Revenue/Share0.0003 USD
Last Price0.0311 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees11
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.39
PEG—
EV/EBITDA-0.22
EV/Revenue35.45
P/S37.69
P/B0.47
EPS (TTM)-1.33
EPS (Forward)-0.08
52W Range
0.02900% of range5.595
52W High5.595 SEK
52W Low0.0290 SEK
Profitability
Gross Margin0.00%
Oper. Margin-18215.31%
EBITDA Margin0.00%
Profit Margin-9990.27%
ROE-748.65%
ROA-46.43%
Growth
Revenue Growth-69.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.92M $
CapEx (TTM)139.75K $
FCF Margin-36347.52%
FCF Yield-967.57%
Net Debt-57.10K $
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity6.29
Current Ratio1.76
Quick Ratio1.21
Book Value/Sh0.0660 SEK
Cash/Share0.0530 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateApr 7, 2025
Analyst Consensus
Rating—
Target (Mean)0.3000 SEK
Upside (mean)+864.6%
Target Range0.3000 SEK – 0.3000 SEK
# Analysts1
Ownership
Shares Out.628.11M
Float613.86M
Insiders1.66%
Institutions2.71%
Technical
SMA 500.1223 (-74.6%)
SMA 2000.2532 (-87.7%)
Beta1.19
S&P 52W Chg18.16%
Avg Vol (30d)14.01M
Avg Vol (10d)11.39M
Technical Indicators
RSI (14)18.4
MACD-0.0286
MACD Signal-0.0320
MACD Hist.+0.0034
BB Upper0.0506 SEK
BB Middle0.0391 SEK
BB Lower0.0277 SEK
BB Width58.54%
ATR (14)0.0093 SEK
Vol Ratio (20d)0.43x